KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Oscar Health (OSCR) Interest Expenses (2020 - 2025)

Oscar Health (OSCR) has disclosed Interest Expenses for 5 consecutive years, with -$1.1 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Interest Expenses fell 118.2% year-over-year to -$1.1 million, compared with a TTM value of $17.6 million through Dec 2025, down 25.84%, and an annual FY2025 reading of $17.6 million, down 25.84% over the prior year.
  • Interest Expenses was -$1.1 million for Q4 2025 at Oscar Health, down from $6.9 million in the prior quarter.
  • Across five years, Interest Expenses topped out at $6.9 million in Q3 2025 and bottomed at -$1.1 million in Q4 2025.
  • Average Interest Expenses over 5 years is $4.7 million, with a median of $6.0 million recorded in 2024.
  • The sharpest move saw Interest Expenses skyrocketed 2593.42% in 2022, then plummeted 118.2% in 2025.
  • Year by year, Interest Expenses stood at $397000.0 in 2021, then skyrocketed by 1445.34% to $6.1 million in 2022, then grew by 1.34% to $6.2 million in 2023, then decreased by 3.07% to $6.0 million in 2024, then plummeted by 118.2% to -$1.1 million in 2025.
  • Business Quant data shows Interest Expenses for OSCR at -$1.1 million in Q4 2025, $6.9 million in Q3 2025, and $5.8 million in Q2 2025.